varenicline has been researched along with Cardiac Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mathieson, K; Olawuyi, O | 1 |
| Boffi, R; Marabelli, C; Munarini, E; Pozzi, P | 1 |
| Aubin, HJ; Benhaddi, H; Bolin, K; de Nigris, E; Marbaix, S; Mork, AC; Wilson, K | 1 |
| Grief, SN | 1 |
1 review(s) available for varenicline and Cardiac Diseases
| Article | Year |
|---|---|
Nicotine dependence: health consequences, smoking cessation therapies, and pharmacotherapy.
Topics: Administration, Cutaneous; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Heart Diseases; Humans; Neoplasms; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Substance-Related Disorders; Varenicline | 2011 |
3 other study(ies) available for varenicline and Cardiac Diseases
| Article | Year |
|---|---|
Pharmacovigilance Assessment of Cardiac Implications of Nicotine Replacement Therapy Among Smokers.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Bupropion; Female; Heart Diseases; Humans; Male; Middle Aged; Nicotinic Agonists; Pharmacovigilance; Retrospective Studies; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; United States; United States Food and Drug Administration; Varenicline; Young Adult | 2020 |
Extended varenicline treatment in a severe cardiopathic cigarette smoker: a case report.
Topics: Bupropion; Counseling; Heart Diseases; Humans; Male; Middle Aged; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2015 |
Cost-effectiveness of varenicline compared with nicotine patches for smoking cessation--results from four European countries.
Topics: Adolescent; Adult; Aged; Benzazepines; Cost-Benefit Analysis; Europe; Female; Heart Diseases; Humans; Incidence; Lung Neoplasms; Male; Markov Chains; Middle Aged; Models, Statistical; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quality-Adjusted Life Years; Quinoxalines; Smoking; Smoking Cessation; Stroke; Varenicline; Young Adult | 2009 |